Timothy L. Moore

CIK: 0001669207

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

BLFS

BIOLIFE SOLUTIONS INC

Director

CERS

CERUS CORP

Director

ALLO

Allogene Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

BLFS
BIOLIFE SOLUTIONS INC
Oct 6, 2026
Disposition(D)
Direct
44.9K shares-
BLFS
BIOLIFE SOLUTIONS INC
Feb 24, 2026
Award(A)
Direct
8.2K shares-
CERS
CERUS CORP
Jun 3, 2025
Award(A)
Direct
60K shares-
BLFS
BIOLIFE SOLUTIONS INC
Mar 18, 2025
Award(A)
Direct
6.9K shares-
ALLO
Allogene Therapeutics, Inc.
Feb 3, 2025
Sale(S)
Direct
14.7K shares at avg. $1.71$25K

		Type	Shares	Price		Ownership
Oct 6, 2026	BLFS BIOLIFE SOLUTIONS INC	Disposition(D)	44,943	-	$0	Direct
Feb 24, 2026	BLFS BIOLIFE SOLUTIONS INC	Award(A)	8,170	-	$0	Direct
Jun 3, 2025	CERS CERUS CORP	Award(A)	60,000	-	-	Direct
Mar 18, 2025	BLFS BIOLIFE SOLUTIONS INC	Award(A)	6,876	-	-	Direct
Feb 3, 2025	ALLO Allogene Therapeutics, Inc.	Sale(S)	14,746	$1.71	$25,216	Direct

1-5 of 5 transactions

About MOORE TIMOTHY L.

MOORE TIMOTHY L. (SEC CIK 0001669207) files insider reports with the SEC as Director of BIOLIFE SOLUTIONS INC (BLFS), Director of CERUS CORP (CERS) and Chief Technical Officer of Allogene Therapeutics, Inc. (ALLO).

Signal8 holds 5 ownership filings by MOORE TIMOTHY L., all Form 4s, filed between Feb 5, 2025 and Oct 8, 2026. Those filings report 5 transactions, from Feb 3, 2025 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MOORE TIMOTHY L.'s filings is in BOTHELL, WA.

Recent filings by MOORE TIMOTHY L.

Oct 6, 2026: Disposition to issuer transaction of BLFS shares (Form 4, code D).
Feb 24, 2026: Grant or award of BLFS shares (Form 4, code A).
Jun 3, 2025: Grant or award of CERS shares (Form 4, code A).
Mar 18, 2025: Grant or award of BLFS shares (Form 4, code A).
Feb 3, 2025: Open-market sale of ALLO shares (Form 4, code S).